These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38261431)

  • 1. Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?
    Arenella M
    Int Clin Psychopharmacol; 2024 Jul; 39(4):220-222. PubMed ID: 38261431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Attention deficit hyperactivity disorder: from a neurodevelopmental perspective].
    Fernandez-Jaen A; Lopez-Martin S; Albert J; Martin Fernandez-Mayoralas D; Fernandez-Perrone AL; Calleja-Perez B; Lopez-Arribas S
    Rev Neurol; 2017 Feb; 64(s01):S101-S104. PubMed ID: 28256695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Neurodevelopmental Disorders: A Key Role for the Immune System.
    Breach MR; Lenz KM
    Curr Top Behav Neurosci; 2023; 62():165-206. PubMed ID: 35435643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Choline in Neurodevelopmental Disorders-A Narrative Review Focusing on ASC, ADHD and Dyslexia.
    Derbyshire E; Maes M
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention deficit hyperactivity and autism spectrum disorders in patients with anorectal malformations.
    Wester T; Gunnarsdottir A; Skoglund C; Svenningsson A
    Acta Paediatr; 2021 Nov; 110(11):3131-3136. PubMed ID: 34498328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of neurodevelopmental disorders in a clinically referred sample of children with CHD.
    Loblein HJ; Vukmirovich PW; Donofrio MT; Sanz JH
    Cardiol Young; 2023 Apr; 33(4):619-626. PubMed ID: 36094009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of Telepsychiatry Assessments Using the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV for Children With Neurodevelopmental Disorders and Their Caregivers: Randomized Feasibility Study.
    Kurokawa S; Nomura K; Hosogane N; Nagasawa T; Kawade Y; Matsumoto Y; Morinaga S; Kaise Y; Higuchi A; Goto A; Inada N; Kodaira M; Kishimoto T
    J Med Internet Res; 2024 Feb; 26():e51749. PubMed ID: 38373022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive immunoprofiling of neurodevelopmental disorders suggests three distinct classes based on increased neurogenesis, Th-1 polarization or IL-1 signaling.
    Sreenivas N; Maes M; Padmanabha H; Dharmendra A; Chakkera P; Paul Choudhury S; Abdul F; Mullapudi T; Gowda VK; Berk M; Vijay Sagar Kommu J; Debnath M
    Brain Behav Immun; 2024 Jan; 115():505-516. PubMed ID: 37972879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination diets' efficacy and mechanisms in attention deficit hyperactivity disorder and autism spectrum disorder.
    Ly V; Bottelier M; Hoekstra PJ; Arias Vasquez A; Buitelaar JK; Rommelse NN
    Eur Child Adolesc Psychiatry; 2017 Sep; 26(9):1067-1079. PubMed ID: 28190137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.
    Juvale IIA; Che Has AT
    J Mol Neurosci; 2021 Jul; 71(7):1338-1355. PubMed ID: 33774758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness of repetitive transcranial magnetic stimulation treatment in children and adolescents with neurodevelopmental disorders: A systematic review.
    Masuda F; Nakajima S; Miyazaki T; Tarumi R; Ogyu K; Wada M; Tsugawa S; Croarkin PE; Mimura M; Noda Y
    Autism; 2019 Oct; 23(7):1614-1629. PubMed ID: 30663323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum.
    Richardson AJ; Ross MA
    Prostaglandins Leukot Essent Fatty Acids; 2000; 63(1-2):1-9. PubMed ID: 10970706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurodevelopment and phenocopies of attention deficit hyperactivity disorder: differential diagnosis].
    Fernandez-Jaen A; Martin Fernandez-Mayoralas D; Fernandez-Perrone AL; Jimenez A; Albert J; Lopez-Martin S; Calleja-Perez B; Tirado P; Lopez-Arribas S
    Rev Neurol; 2018 Mar; 66(S01):S103-S107. PubMed ID: 29516461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in neurodevelopmental disorders.
    May T; Adesina I; McGillivray J; Rinehart NJ
    Curr Opin Neurol; 2019 Aug; 32(4):622-626. PubMed ID: 31135460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-morbidity in Attention-Deficit Hyperactivity Disorder: A Clinical Study from India.
    Jacob P; Srinath S; Girimaji S; Seshadri S; Sagar JV
    East Asian Arch Psychiatry; 2016 Dec; 26(4):148-53. PubMed ID: 28053283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of polycystic ovary syndrome or anovulatory infertility with offspring psychiatric and mild neurodevelopmental disorders: a Finnish population-based cohort study.
    Chen X; Kong L; Piltonen TT; Gissler M; Lavebratt C
    Hum Reprod; 2020 Oct; 35(10):2336-2347. PubMed ID: 32866965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review evaluating the implementation of technologies to assess, monitor and treat neurodevelopmental disorders: A map of the current evidence.
    Valentine AZ; Brown BJ; Groom MJ; Young E; Hollis C; Hall CL
    Clin Psychol Rev; 2020 Aug; 80():101870. PubMed ID: 32712216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of the risk faced by pedestrians with neurodevelopmental disorders: A systematic review.
    Wilmut K; Purcell C
    Accid Anal Prev; 2021 Jan; 149():105886. PubMed ID: 33248701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Length impairments of the axon initial segment in rodent models of attention-deficit hyperactivity disorder and autism spectrum disorder.
    Usui N; Tian X; Harigai W; Togawa S; Utsunomiya R; Doi T; Miyoshi K; Shinoda K; Tanaka J; Shimada S; Katayama T; Yoshimura T
    Neurochem Int; 2022 Feb; 153():105273. PubMed ID: 34971749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.